TNXP
Tonix Pharmaceuticals Holding Corp.
NASDAQ · Healthcare · Biotechnology · US
$10.87
−4.82%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$2.45
- Revenue estimate
- $15.9M
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$2.44
- EPS estimate
- -$2.64
- Revenue actual
- $13.5M
- Revenue estimate
- $7.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -22.3%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$2.64 | -$2.44 | Beat 7.58% | $13.5M |
| May 11, 2026 | -$2.54 | -$2.93 | Miss -15.35% | $6.9M |
| Mar 12, 2026 | -$3.19 | -$3.98 | Miss -24.76% | $5.4M |
| Mar 18, 2025 | -$6.23 | -$9.77 | Miss -56.82% | $2.6M |
| Aug 16, 2024 | -$991 | -$1.9K | Miss -94.55% | $2.2M |
| Apr 1, 2024 | -$5.0K | -$2.7K | Beat 44.87% | $2.5M |
| Nov 9, 2023 | -$4.8K | -$5.8K | Miss -22.82% | $4.0M |
| Aug 10, 2023 | -$8.9K | -$8.6K | Beat 3.60% | — |
| Mar 13, 2023 | -$12.6K | -$11.2K | Beat 11.11% | — |
| Mar 14, 2022 | -$44.7K | -$44.7K | In line | — |
| Mar 15, 2021 | -$57.4K | -$63.8K | Miss -11.11% | $2.9M |
| May 12, 2020 | -$312.6K | -$236.0K | Beat 24.49% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026